Reducing carbon footprint by switching to reusable soft-mist inhalers
Sign Up to like & getrecommendations! Published in 2023 at "ERJ Open Research"
DOI: 10.1183/23120541.00543-2022
Abstract: Objective Inhalation therapy is the cornerstone of COPD, together with non-pharmacological treatments. Long-acting muscarinic antagonists (LAMAs), alone or in combination with long-acting β-agonists (LABAs), are commonly used. Pressurised metered-dose inhalers (pMDIs), dry powder inhalers (DPIs)… read more here.
Keywords: carbon footprint; lama; carbon; respimat reusable ... See more keywords